Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis

Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products. The post Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis appeared first on MedCity News.

Read More

What Will Separate Healthcare AI Winners From Losers?

Uma Veerappan of Flare Capital Partners thinks the healthcare AI startups that will come out on top will be companies that integrate seamlessly into workflows, build proprietary datasets and quickly determine how to sell their technology. The post What Will Separate Healthcare AI Winners From Losers? appeared first on MedCity News.

Read More

Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously 

Shyld AI has raised $13.4 million to expand its AI-powered UV disinfection platform, which autonomously sanitizes hospital rooms. The startup’s technology aims to reduce the risk of hospital-acquired infection, as well as lessen hospitals’ reliance on labor-intensive cleaning workflows. The post Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously  appeared first on…

Read More